Once for Life

Once for Life

Creating transformational gene therapies and peptide infusions that treat the most prevalent diseases to restore health and renew life.

Renova Therapeutics envisions a future in which we’re able to permanently treat chronic diseases with gene and peptide therapies. Right now, we’re developing definitive, one-time treatments to restore health to people suffering from some of the most common and devastating chronic conditions in the world: congestive heart failure and type 2 diabetes.

Tell Us Who You Are, And We'll Guide You Through our Site


Latest News:  Jan. 5, 2017: Renova Therapeutics selects Worldwide Clinical Trials as its Clinical Research Organization for Phase 3 trial of RT-100 AC6 gene transfer

  Dec. 8, 2016: Renova Therapeutics secures novel AAV vector license for use in metabolic and cardiovascular gene therapy development

View All News
Subscribe to receive company press releases and announcements